BRIEF published on 04/08/2025 at 07:48, 1 year 6 months ago GenSight Biologics dépose son document d'enregistrement universel 2024 Document D'Enregistrement Universel GenSight Biologics Thérapies Géniques Maladies De La Rétine Rapport Financier 2024
PRESS RELEASE published on 04/08/2025 at 07:46, 1 year 6 months ago INFORMATIONS PRIVILÉGIÉES / AUTRES COMMUNIQUÉS GenSight Biologics met à disposition son Document d'Enregistrement Universel 2024 pour consultation en ligne Document D'Enregistrement Universel GenSight Biologics Thérapies Géniques Maladies Neurodégénératives Rétine
PRESS RELEASE published on 04/08/2025 at 07:43, 1 year 6 months ago INSIDE INFORMATION / OTHER NEWS RELEASES GenSight Biologics announces the filing of its 2024 Universal Registration Document with the French market authority, including financial reports and corporate governance details GenSight Biologics Gene Therapies Retinal Neurodegenerative Diseases 2024 Universal Registration Document Central Nervous System Disorders
BRIEF published on 04/07/2025 at 20:19, 1 year 6 months ago GenSight Biologics Financial and Business Update Fundraising Clinical Trials Gene Therapy Financial Update GenSight Biologics
BRIEF published on 04/07/2025 at 20:19, 1 year 6 months ago Mise à jour financière et commerciale de GenSight Biologics Essais Cliniques Thérapie Génique Mise À Jour Financière Collecte De Fonds GenSight Biologics
PRESS RELEASE published on 04/07/2025 at 20:14, 1 year 6 months ago Inside Information / News release on accounts, results GenSight Biologics reports cash position and business update as of March 31, 2025. Discussions with French agency progressing. Fundraising planned for Phase III trial and marketing advancement Business Update Cash Position Fundraising Activities GenSight Biologics RECOVER Phase III Trial
PRESS RELEASE published on 04/07/2025 at 20:14, 1 year 6 months ago Informations privilégiées / Communiqué sur comptes, résultats GenSight Biologics publie sa situation de trésorerie au 31 mars 2025, annonce des activités de levées de fonds pour prolonger l'horizon de trésorerie et fait le point sur ses activités Trésorerie Essai Clinique GenSight Biologics Thérapies Géniques Levées De Fonds
BRIEF published on 03/17/2025 at 07:35, 1 year 7 months ago GenSight Biologics Présente LUMEVOQ® au Congrès NANOS 2025 Thérapie Génique GenSight Biologics LUMEVOQ® NOHL Congrès NANOS
BRIEF published on 03/17/2025 at 07:35, 1 year 7 months ago GenSight Biologics Presents LUMEVOQ® at NANOS 2025 Gene Therapy GenSight Biologics LUMEVOQ® NOHL NANOS Congress
PRESS RELEASE published on 03/17/2025 at 07:30, 1 year 7 months ago Informations privilégiées / Autres communiqués GenSight Biologics annonce des communications scientifiques sur LUMEVOQ® au Congrès 2025 du NANOS. Nouvelles données sur la thérapie génique pour NOHL Thérapie Génique GenSight Biologics NOHL LUMEVOQ NEURO-OPHTALMOLOGIE
Published on 10/17/2026 at 03:20, 21 hours 48 minutes ago Battery X Metals Highlights Participation at X Takeover 2026, an Electric Vehicle and Emerging Technology Event Held at Tesla's Gigafactory Texas, Providing Exposure to Industry Perspectives and Technology Developments
Published on 10/17/2026 at 03:15, 21 hours 53 minutes ago Vanta Closes Second Tranche of Private Placement Financing and Welcomes Launch of First U.S.-Listed Peptide ETF, Highlighting Growing Recognition of Peptide Industry
Published on 10/16/2026 at 23:35, 1 day 1 hour ago Initial Closing of US$3.4 Million Private Placement
Published on 10/16/2026 at 23:30, 1 day 1 hour ago NiobiumX Mining Inc. Announces Retraction of Recent Marketing Materials
Published on 10/16/2026 at 23:00, 1 day 2 hours ago Grid Announces Adoption of Advance Notice By-Law and Provides Shareholder Meeting Update
Published on 10/17/2026 at 18:00, 7 hours 8 minutes ago Baader Bank announces extended trading hours 23 hours a day starting Q1/2027
Published on 10/17/2026 at 13:05, 12 hours 2 minutes ago Luong Quoi Coconut Vietnam to Showcase Vietnamese Coconut Expertise at SIAL Paris 2026
Published on 10/17/2026 at 12:50, 12 hours 17 minutes ago AGFUND wins international award for excellence in inclusive banking and social impact
Published on 10/16/2026 at 20:08, 1 day 4 hours ago EQS-Adhoc: Rath AG // Rath Group reaches agreement with its key financial creditors on the terms of a transformation agreement and launches a transformation programme
Published on 10/16/2026 at 19:20, 1 day 5 hours ago Arity to Acquire INRIX, Advancing a Connected Vision for the Future of Transportation
Published on 10/16/2026 at 19:54, 1 day 5 hours ago ENGIE - Déclaration du nombre total d'actions et de droits de vote au 30 septembre 2026
Published on 10/16/2026 at 18:48, 1 day 6 hours ago Disclosure of transactions in own shares from October 12 to October 16, 2026
Published on 10/16/2026 at 18:48, 1 day 6 hours ago Déclaration hebdomadaire d'opérations effectuées du 12 au 16 octobre 2026
Published on 10/16/2026 at 18:00, 1 day 7 hours ago KLARSEN : Compte rendu AGO et AGE du 8 octobre 2026
